[Pharmaceutical and Bio News] SK Bioscience signs contract for contract manufacturing of MSD Ebola vaccine
SK Bioscience announced a partnership with global pharmaceutical company MSD to participate in the development project for an Ebola vaccine supported by CEPI.
Africa: Ebola Has Gone From a Global Emergency to a Disease We Can Stop, Says CEPI Chief
Dr. Richard Hatchett, CEO of CEPI, highlights the significant advancements made in controlling Ebola but warns of ongoing challenges.